JP2003513034A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003513034A5 JP2003513034A5 JP2001534359A JP2001534359A JP2003513034A5 JP 2003513034 A5 JP2003513034 A5 JP 2003513034A5 JP 2001534359 A JP2001534359 A JP 2001534359A JP 2001534359 A JP2001534359 A JP 2001534359A JP 2003513034 A5 JP2003513034 A5 JP 2003513034A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- subject
- called
- transplantation
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- YCPOZVAOBBQLRI-WDSKDSINSA-N Treosulfan Chemical compound CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O YCPOZVAOBBQLRI-WDSKDSINSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 229960003181 treosulfan Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19953517.5 | 1999-11-05 | ||
| DE19953517A DE19953517C1 (de) | 1999-11-05 | 1999-11-05 | Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation |
| PCT/EP2000/010871 WO2001032154A2 (de) | 1999-11-05 | 2000-11-03 | Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003513034A JP2003513034A (ja) | 2003-04-08 |
| JP2003513034A5 true JP2003513034A5 (cg-RX-API-DMAC7.html) | 2011-10-13 |
| JP4846151B2 JP4846151B2 (ja) | 2011-12-28 |
Family
ID=7928187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001534359A Expired - Fee Related JP4846151B2 (ja) | 1999-11-05 | 2000-11-03 | 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7199162B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1227808B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4846151B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE251455T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU777527B2 (cg-RX-API-DMAC7.html) |
| BG (1) | BG65845B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2389896C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ299701B6 (cg-RX-API-DMAC7.html) |
| DE (2) | DE19953517C1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA004543B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2208435T3 (cg-RX-API-DMAC7.html) |
| HU (2) | HU227332B1 (cg-RX-API-DMAC7.html) |
| NO (2) | NO329616B1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL212132B1 (cg-RX-API-DMAC7.html) |
| UA (1) | UA73961C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001032154A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237146A1 (de) * | 2002-08-13 | 2004-03-04 | Medac Gesellschaft für klinische Spezialpräparate mbH | Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose |
| JP7431815B2 (ja) * | 2018-09-26 | 2024-02-15 | メダック ゲゼルシャフト フィア クリニッシェ スペツィアルプレパラーテ ミット ベシュレンクタ ハフトゥンク | トレオスルファンの結晶形 |
| PT4257122T (pt) | 2018-09-26 | 2026-06-08 | Medac Ges Fr Klinische Spezialprparate Mbh | Liofilizado de treossulfano |
| EP3856252A1 (en) | 2018-09-26 | 2021-08-04 | medac Gesellschaft für klinische Spezialpräparate mbH | Solution comprising treosulfan |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376546A (en) * | 1991-11-04 | 1994-12-27 | Xoma Corporation | Analogs of ribosome-inactivating proteins |
| DE4421391C1 (de) * | 1994-06-18 | 1995-11-30 | Gsf Forschungszentrum Umwelt | Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression |
| WO2000045842A2 (en) * | 1999-02-04 | 2000-08-10 | The General Hospital Corporation | Methods for human allografting |
-
1999
- 1999-11-05 DE DE19953517A patent/DE19953517C1/de not_active Expired - Lifetime
-
2000
- 2000-03-11 UA UA2002054343A patent/UA73961C2/uk unknown
- 2000-11-03 JP JP2001534359A patent/JP4846151B2/ja not_active Expired - Fee Related
- 2000-11-03 DE DE50004024T patent/DE50004024D1/de not_active Expired - Lifetime
- 2000-11-03 PL PL356240A patent/PL212132B1/pl unknown
- 2000-11-03 EA EA200200535A patent/EA004543B1/ru not_active IP Right Cessation
- 2000-11-03 ES ES00975995T patent/ES2208435T3/es not_active Expired - Lifetime
- 2000-11-03 CZ CZ20021562A patent/CZ299701B6/cs not_active IP Right Cessation
- 2000-11-03 AT AT00975995T patent/ATE251455T1/de not_active IP Right Cessation
- 2000-11-03 US US10/129,352 patent/US7199162B1/en not_active Expired - Lifetime
- 2000-11-03 AU AU13918/01A patent/AU777527B2/en not_active Expired
- 2000-11-03 CA CA002389896A patent/CA2389896C/en not_active Expired - Lifetime
- 2000-11-03 WO PCT/EP2000/010871 patent/WO2001032154A2/de not_active Ceased
- 2000-11-03 HU HU0203277A patent/HU227332B1/hu active Protection Beyond IP Right Term
- 2000-11-03 EP EP00975995A patent/EP1227808B1/de not_active Expired - Lifetime
-
2002
- 2002-05-02 NO NO20022109A patent/NO329616B1/no not_active IP Right Cessation
- 2002-06-04 BG BG106772A patent/BG65845B1/bg unknown
-
2019
- 2019-07-23 NO NO2019032C patent/NO2019032I1/no unknown
- 2019-09-18 HU HUS1900041 patent/HUS1900041I1/hu unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2387542A1 (en) | Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation | |
| GEP20032976B (en) | Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant | |
| DK1699915T3 (da) | Anvendelse af erythropoietin til levervævsregenerering | |
| DE69836822D1 (de) | Verfahren zur Behandlung von Kapseln und trockenen gepulverten pharmazeutischen Formulierungen | |
| SG146666A1 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
| WO2007024441A3 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
| CA2416492A1 (en) | Treatment of glycogen storage disease type ii | |
| HK1052301A1 (zh) | α(2)巨球蛋白与抗原分子的复合物作免疫治疗用途 | |
| HUS1900041I1 (hu) | Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására | |
| Satilmis et al. | Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis | |
| AP1896A (en) | The method of treating cancer | |
| JP2002171966A5 (cg-RX-API-DMAC7.html) | ||
| ATE297217T1 (de) | Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung | |
| DE60033840D1 (de) | Antisense-zusammensetzungen und verfahren zur behandlung von krebs | |
| EP1211311A3 (en) | Cord blood-derived activated lymphocytes and preparations containing said lymphocytes | |
| JP2002534393A5 (cg-RX-API-DMAC7.html) | ||
| DK0652943T3 (da) | Hæmatopoietiske, fremmende celler og anvendelse deraf | |
| MXPA03001644A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
| MD1005G2 (ro) | Procedeu de obţinere a cărbunilor activi | |
| Zhong et al. | LONG-TERM LIMB ALLOGRAFT SURVIVAL USING A SHORT COURSE OF ANTI-CD45RB MONOCLONAL ANTIBODY, LF15-0195 AND RAPAMYCIN IN A MOUSE MODEL. | |
| Ren et al. | Co-transplantation of umbilical cord blood mesenchymal stem cells and haploidentical hematopoietic stem cells for treatment of severe aplastic anemia | |
| RU2000124826A (ru) | Способ лечения больных с затяжной пневмонией | |
| Plett et al. | Homing of primitive hematopoietic cells in non-myeloablated murine recipients | |
| NZ512123A (en) | Isolated material having an anti-organotrophic effect where the material is purified from prepared ovarian venous plasma | |
| Bug et al. | Stem cell and cord blood transplantation–state of the art |